The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
The gut microbiome puzzle and probiotics in primary care patients with IBS
16 Feb 2026by GMFH Editing Team
Gut microbiome-related interventions for the management of disorders of gut-brain interaction were on the agenda of NeuroGASTRO 2025. In this video interview, Dr. Juan M. Mendive delves into the role of the gut microbiome for improving outcomes of primary care patients with IBS.
Specific probiotic species and strains could help manage chronic constipation in adults
2 Feb 2026by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines show that psyllium, certain probiotic strains and magnesium oxide supplements can help to improve constipation.
Carbohydrate malabsorption is an underlying cause of irritable bowel syndrome-type symptoms in some patients. This article explores the impact of fermentable short-chain carbohydrates (FODMAPs) on gut function, the benefits and risks of a low-FODMAP diet, and how probiotics can help individuals with carbohydrate malabsorption.
The fourth edition of IBS Days covered the latest IBS diagnosis and treatment advances in a postgraduate course. Read about the highlights and discussions (part 2).
IBS Days 2024: what’s new in the pathophysiology of IBS, overlapping conditions, and non-prescription microbiome-based therapeutics?
12 Aug 2024by Andreu Prados
June 17-19 2024, Gut Microbiota for Health attended the fourth edition of IBS Days 2024 in Bologna, Italy, alongside 400 in-person attendees. Find out more about the most relevant basic, translational, and clinical science highlights in IBS (part 1).
Why addressing how our brain and our gut talk to each other matter for IBS
19 Feb 2024by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
Alterations in the gut microbiome composition and functions are emerging as a potential target for managing IBS. Discover how microbiota-modifying treatments, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation, hold promise in alleviating symptoms of this vexing condition.
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
4 Dec 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
Research highlights from NeuroGASTRO 2023: food, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction
6 Nov 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of the gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more what the latest research says about the involvement of the intestinal microbiota, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction and dietary considerations in their management picked up by GMFH editors (Part 1).
